Michael Saathoff
Psychiatry · Pueblo, CONPI 1235174160
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 28.7% of the total. Reporting peaked in 2019 at $988 and has fallen 79.5% since, to $202 in 2023. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 113 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$583
- Vanda Pharmaceuticals Inc.$298
- Takeda Pharmaceuticals U.S.A., Inc.$228
- Otsuka America Pharmaceutical, Inc.$188
- Sunovion Pharmaceuticals Inc.$160
- Neurocrine Biosciences, Inc.$122
- plus $449 from 10 others
What the payments were for
- Food & beverage$1,96097%
- Education$683%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $583 |
| Vanda Pharmaceuticals Inc. | 15 | $298 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $228 |
| Otsuka America Pharmaceutical, Inc. | 9 | $188 |
| Sunovion Pharmaceuticals Inc. | 12 | $160 |
| Neurocrine Biosciences, Inc. | 7 | $122 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $92 |
| Lundbeck LLC | 4 | $71 |
| Alkermes, Inc. | 4 | $62 |
| Ironshore Pharmaceuticals Inc. | 3 | $56 |
| Shire North American Group Inc | 3 | $44 |
| Johnson & Johnson | 3 | $42 |
| Avanir Pharmaceuticals, Inc. | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Corium, LLC | 1 | $21 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
How this compares
$2,029 in reported general payments places this provider in the 90th percentile of 559 psychiatry providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clomipramine Hcl | 11 | $1,083 |
| Olanzapine | 11 | $128 |
| Gabapentin | 16 | $101 |
| Escitalopram Oxalate | 12 | $58 |
| Sertraline Hcl | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Pueblo
- John HardyPueblo$828K
- John DequardoPueblo$17K
- Musharraf NizamiPueblo$6K
- Artin TerhakopianPueblo$2K
- Larry SandersLittleton$760K
- Jeffrey RichmondDenver$424K
- Jennifer FrenchGlendale$115K
- Charles ParkLone Tree$89K
- Cynthia EppersonAurora$64K
- Brian WiseCentennial$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.